1. Home
  2. RLAY vs PIPR Comparison

RLAY vs PIPR Comparison

Compare RLAY & PIPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$19.35

Market Cap

4.1B

Sector

Health Care

ML Signal

HOLD

Logo Piper Sandler Companies

PIPR

Piper Sandler Companies

HOLD

Current Price

$72.74

Market Cap

5.5B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
RLAY
PIPR
Founded
2015
1895
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Investment Bankers/Brokers/Service
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
5.5B
IPO Year
2020
2003

Fundamental Metrics

Financial Performance
Metric
RLAY
PIPR
Price
$19.35
$72.74
Analyst Decision
Strong Buy
Buy
Analyst Count
10
3
Target Price
$19.50
$91.38
AVG Volume (30 Days)
2.8M
499.4K
Earning Date
05-05-2026
05-01-2026
Dividend Yield
N/A
2.26%
EPS Growth
31.78
54.49
EPS
N/A
1.87
Revenue
$15,355,000.00
$1,904,217,000.00
Revenue This Year
N/A
$12.30
Revenue Next Year
$324.03
$13.55
P/E Ratio
N/A
$39.50
Revenue Growth
53.44
24.33
52 Week Low
$4.32
$69.16
52 Week High
$21.27
$380.26

Technical Indicators

Market Signals
Indicator
RLAY
PIPR
Relative Strength Index (RSI) 42.46 47.65
Support Level $18.03 $73.36
Resistance Level $20.82 $78.49
Average True Range (ATR) 0.69 1.98
MACD -0.06 -0.21
Stochastic Oscillator 20.12 50.76

Price Performance

Historical Comparison
RLAY
PIPR

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.

About PIPR Piper Sandler Companies

Piper Sandler Cos is an investment bank and institutional securities firm, serving the needs of corporations, private equity groups, public entities, non-profit entities, and institutional investors in the United States (U.S.) and internationally. The company provides a broad set of products and services, including financial advisory services; equity and debt capital markets products; public finance services; institutional brokerage services; fundamental equity and macro research services; fixed income services; and alternative asset management strategies. It generates maximum revenue from Advisory services.

Share on Social Networks: